Literature DB >> 27000614

Successful Treatment of Invasive Pulmonary Mucormycosis in an Immunocompromised Patient.

Oluwatobi Afolayan1, Hannah Copeland1, Rachel Hargrove1, Salman Zaheer1, Jason M Wallen2.   

Abstract

A 59-year-old man undergoing chemotherapy for acute myelogenous leukemia had a bilateral pneumonic process. The right lung subsequently developed several small cavitary lesions extending from the central hilum to the chest wall. Despite medical therapy, repeat imaging demonstrated coalescence into a single, large, central cavitary lesion. Thoracic surgery was consulted because of the central hilar involvement of all three lobes; a pneumonectomy would have been required to resect the lesion. However, he was not a candidate for pneumonectomy because of a low predicted postoperative forced expiratory volume in 1 second. We performed a rib resection, debridement, and marsupialization, in which the skin was sewn circumferentially to the parietal pleura. His wound was managed with wet-to-dry dressings. Postoperatively, he recovered well, with resolution of his cough. Three weeks after surgery, he was discharged from the hospital, and the cavity completely closed at 4 months.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27000614     DOI: 10.1016/j.athoracsur.2015.09.098

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

2.  Characteristics of pulmonary mucormycosis and the experiences of surgical resection.

Authors:  Weipeng Shao; Jun Zhang; Shanwu Ma; Hongxiang Feng; Zhenrong Zhang; Chaoyang Liang; Deruo Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

3.  Covid-associated pulmonary mucormycosis.

Authors:  Arvind Kumar; Mohan V Pulle; Belal B Asaf; Harsh V Puri
Journal:  Lung India       Date:  2022 Mar-Apr

4.  Pulmonary mucormycosis: a case of pulmonary arterial hypertension, Westermark sign, and bronchopleural fistula.

Authors:  Weipeng Shao; Zhenrong Zhang; Hongxiang Feng; Chaoyang Liang; Deruo Liu
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

5.  Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis.

Authors:  Mohan Venkatesh Pulle; Harsh Vardhan Puri; Belal Bin Asaf; Sukhram Bishnoi; Shikha Sharma; Arvind Kumar
Journal:  Lung India       Date:  2021 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.